China Pharma Holdings
CPHI
4 hedge funds and large institutions have $14K invested in China Pharma Holdings in 2024 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 0 increasing their positions, reducing their positions, and 3 closing their positions.
33% more funds holding
Funds holding: 3 → 4 (+1)
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
0.06% less ownership
Funds ownership: 0.1% → 0.04% (-0.06%)
68% less capital invested
Capital invested by funds: $43K → $14K (-$29K)
Top Buyers
Top Sellers
| 1 |
Citadel Advisors
Miami,
Florida
|
-$35K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$5.3K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$2.72K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
XT
1
XTX Topco
George Town,
Cayman Islands
| $7.14K | +$8.82K | +2,874 | New |
|
|
BBA
2
Baader Bank Aktiengesellschaft
Unterschleissheim,
Germany
| $4.11K | +$6.23K | +2,031 | New |
|
3
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $2.71K | +$3.35K | +1,092 | New |
|
|
FCT
4
First Community Trust
Dubuque,
Iowa
| $7 | +$9 | +3 | New |
|
|
5
Citadel Advisors
Miami,
Florida
| – | -$35K | -9,430 | Closed |
|
|
TSS
6
Two Sigma Securities
New York
| – | -$5.3K | -1,428 | Closed |
|
|
7
UBS Group
Zurich,
Switzerland
| – | -$2.72K | -734 | Closed |
|
CPHI Hedge Fund Activity: Q2 2024 in Review
4 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in China Pharma Holdings (CPHI) for Q2 2024, worth a combined $14K — down 68% from $43K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new CPHI positions and 3 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was XTX Topco, opening a new position worth an estimated $8.82K. The largest seller was Citadel Advisors, exiting entirely with an estimated $35K sold.
- 4 institutional investors held China Pharma Holdings (CPHI) as of Q2 2024, up from 3 in Q1 2024.
- Funds reported $14K of China Pharma Holdings stock for Q2 2024, down 68% quarter-over-quarter.
- 4 funds opened new China Pharma Holdings positions in Q2 2024 and 3 closed out, a net change of +1 holder.
- The largest China Pharma Holdings buyer in Q2 2024 was XTX Topco, an estimated $8.82K added.
- The largest China Pharma Holdings seller in Q2 2024 was Citadel Advisors, an estimated $35K sold.
Based on aggregated 13F filings for Q2 2024.